← ANALYST RATINGS · TIPRANKS
National Research (NRC): analyst forecast and price target
Analyst consensus
Moderate Buy1 Buy0 Hold0 Sell
Ratings of 1 analysts in the last 3 months12-month forecast
Based on 1 price targets given in the last 3 months, the average target is $26.00, the highest $26.00, the lowest $26.00. The average is +29.0% from the last price of $20.15.
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI Google Medical - Healthcare Information ServicesGemini 3-pro | TipRanks - Google | $21.00 | Hold | +4.2% | Reiterated | 12.08.26on TipRanks 00:06 | — | |
| AI xAi Medical - Healthcare Information ServicesxAI Grok-3 | TipRanks - xAI | $21.00 | Hold | +4.2% | Reiterated | 12.08.26on TipRanks 00:06 | — | |
| AI Anthropic Medical - Healthcare Information ServicesAnthropic Opus-4.5 | TipRanks - Anthropic | $19.50 → $20.00+2.6% | Sell | −0.7% | Downgrade | 12.08.26on TipRanks 00:06 | — | |
| AI DeepSeek Medical - Healthcare Information ServicesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $21.50 → $21.00−2.3% | Hold | +4.2% | Reiterated | 12.08.26on TipRanks 00:06 | — | |
| AI OpenAI Medical - Healthcare Information ServicesOpenAI 5.2 | TipRanks - OpenAI | $20.50 → $21.00+2.4% | Hold | +4.2% | Reiterated | 12.08.26on TipRanks 00:06 | — | |
| AI PerPlexity Medical - Healthcare Information ServicesPerPlexity SonarPro | TipRanks - PerPlexity | $21.00 | Hold | +4.2% | Reiterated | 12.08.26on TipRanks 00:06 | — | |
| Constantine Davides★★★★★★★★★★#12158 · hits 36% · avg −12.7% | Citizens JMP | $23.00 → $26.00+13.0% | Buy | +29.0% | Reiterated | 29.07.26on TipRanks 05:51 | −16.5%next day +1.7% · 5 days +1.2% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering National Research
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $26.00 at a price of $21.19 (+22.7%); now: $26.00 at $20.15 (+29.0%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 1 | 2 | 2 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 03.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $0.21 (from $0.21 to $0.21). Last quarter: $0.31.
Sales
Next quarter’s sales estimate — $36M (from $36M to $36M). Last quarter: $35M.
Best top-analyst consensus in the sector · Healthcare
About National Research
- CEO: Trent Green
- Employees: 357
- 1245 Q Street, Lincoln, NE, 68508, US
- nrchealth.com
National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.
Data from the stock’s TipRanks forecast page, read 109 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗